Pharmaceuticals Portfolio Pharmaceuticals Fund Alpha and Beta Analysis
| FPHAX Fund | USD 26.36 0.20 0.75% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Pharmaceuticals Portfolio Pharmaceuticals. It also helps investors analyze the systematic and unsystematic risks associated with investing in Pharmaceuticals Portfolio over a specified time horizon. Remember, high Pharmaceuticals Portfolio's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Pharmaceuticals Portfolio's market risk premium analysis include:
Beta 0.96 | Alpha 0.0496 | Risk 0.93 | Sharpe Ratio 0.17 | Expected Return 0.15 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Pharmaceuticals |
Pharmaceuticals Portfolio Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Pharmaceuticals Portfolio market risk premium is the additional return an investor will receive from holding Pharmaceuticals Portfolio long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Pharmaceuticals Portfolio. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Pharmaceuticals Portfolio's performance over market.| α | 0.05 | β | 0.96 |
Pharmaceuticals Portfolio expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Pharmaceuticals Portfolio's Buy-and-hold return. Our buy-and-hold chart shows how Pharmaceuticals Portfolio performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Pharmaceuticals Portfolio Market Price Analysis
Market price analysis indicators help investors to evaluate how Pharmaceuticals Portfolio mutual fund reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Pharmaceuticals Portfolio shares will generate the highest return on investment. By understating and applying Pharmaceuticals Portfolio mutual fund market price indicators, traders can identify Pharmaceuticals Portfolio position entry and exit signals to maximize returns.
Pharmaceuticals Portfolio Return and Market Media
The median price of Pharmaceuticals Portfolio for the period between Wed, Jan 17, 2024 and Tue, Apr 16, 2024 is 26.86 with a coefficient of variation of 4.81. The daily time series for the period is distributed with a sample standard deviation of 1.26, arithmetic mean of 26.24, and mean deviation of 1.11. The Fund received some media coverage during the period. Price Growth (%) |
| Timeline |
1 | Buy These 3 Healthcare Mutual Funds to Boost Your Portfolio - Yahoo Finance | 03/01/2024 |
2 | 3 Fidelity Mutual Funds to Buy Now for Long-Term Growth - Yahoo Finance | 03/11/2024 |
About Pharmaceuticals Portfolio Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Pharmaceuticals or other funds. Alpha measures the amount that position in Pharmaceuticals Portfolio has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Pharmaceuticals Portfolio in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Pharmaceuticals Portfolio's short interest history, or implied volatility extrapolated from Pharmaceuticals Portfolio options trading.
Build Portfolio with Pharmaceuticals Portfolio
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Pharmaceuticals Portfolio Backtesting, Portfolio Optimization, Pharmaceuticals Portfolio Correlation, Pharmaceuticals Portfolio Hype Analysis, Pharmaceuticals Portfolio Volatility, Pharmaceuticals Portfolio History and analyze Pharmaceuticals Portfolio Performance. Note that the Pharmaceuticals Portfolio information on this page should be used as a complementary analysis to other Pharmaceuticals Portfolio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Pharmaceuticals Portfolio technical mutual fund analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, fund market cycles, or different charting patterns.